Clinical trials are essential for advancing medical treatments of various illnesses. Participating in a clinical trial has many benefits to you, your family, and the patient population that shares your illness now or in the future. While each study will carry many benefits to the individual, they all have some shared benefits that help the wider community.
Participating in a study is easy and you will have:
Access to a team of experienced healthcare professionals every step of the way, at no cost to you
Free access to innovative medication or treatments that may not otherwise be available
Help the development of future cures
Prevention Vaccine (Covid-19)
The AZD1222 COVID-19 VACCINE Study is researching an investigational vaccine for the prevention of COVID-19, the disease caused by the new coronavirus (SARS-CoV-2). The study will see how safe the investigational vaccine is and how well it works. Learn More
Cold and Flu Symptoms Study
We are currently conducting a clinical research program on healthy adults who experience cold and flu symptoms. Eligible patients will attend a single, in-office appointment when flu or cold-like symptoms are present; we estimate the visit to take 30-45 minutes. The research staff will confirm symptoms, take your temperature, perform a fingerstick, and perform a blood draw.
Those who qualify will be compensated $50 for their time.
Low Testosterone Study
The primary purpose of this study is to compare the effect of testosterone replacement therapy (TRT) and matching placebo on major cardiovascular events. These include heart attack and stroke in men who do not produce and have symptoms of testosterone deficiency (hypogonadal men).
This is a phase 4, randomized, double-blind, placebo-controlled, multicenter study of topical (rubbed onto the skin) TRT in men with low testosterone (hypogonadal). “Phase 4” means that AndroGel 1.62% has already been approved by the FDA to treat certain causes of low testosterone, and this is a study to answer further questions about the effect of TRT, which could not be answered in earlier studies before the drug was formally approved.
Previous clinical research includes:
Osteoarthritis of the Knee:
a Phase 2, Randomized, Double-Blind, Placebo-Controlled, Single Dose Study in Moderate to Severe, Painful Osteoarthritis of the Knee
a Phase 2b, Prospective, Double Blinded, Randomized Controlled Trial of Micronized Injection Las Compared to Saline Placebo Injection in The Treatment Of Osteoarthritis Of The Knee
Cologuard: Observational Study of Sub-Populations From “A Longitudinal Study of Cologuard In An Average Risk Population Assessing A Three Year Test Interval”
Colorectal Cancer Screening: Blood and Stool Sample Collection in Subjects Participating In Colorectal Cancer Screening: Act Bold
Asthma: A multicenter, randomized, parallel-group, placebo-controlled, 4-week clinical endpoint bioequivalence study comparing fluticasone propionate/salmeterol 100/50 μg inhalation powder (Cipla Ltd., India) with Advair® Diskus 100/50 μg (GlaxoSmithKline, USA) in asthma patients